Entering text into the input field will update the search result below

Aethlon Medical's (AEMD) CEO Jim Joyce on Q2 2018 Results - Earnings Call Transcript

Nov. 04, 2017 8:53 AM ETAethlon Medical, Inc. (AEMD)
SA Transcripts profile picture
SA Transcripts

Aethlon Medical, Inc. (NASDAQ:AEMD) Q2 2018 Earnings Conference Call November 2, 2017 4:30 PM ET


Scott Gordon – Investor Relations-CoreIR

Jim Joyce – Chairman, Chief Executive Officer and Secretary

Jim Frakes – Chief Financial Officer and Senior Vice President-Finance


Brian Marckx – Zacks Investment Research

Marc Robins – Catalyst Research


Good afternoon and welcome to the Aethlon Medical Earnings Conference Call for the Second Quarter Fiscal 2018. All participants will be in listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Participants of this call are advised that the audio of this conference call is being broadcast live over the internet and is also being recorded for playback purposes. A replay of the call will be available approximately one hour after the end of the call through November 09, 2017.

I would now like to turn the conference over to Scott Gordon, President of Core IR, the company's Investor Relations firm. Please go ahead, sir.

Scott Gordon

Thank you, Rachel, and thank you for joining today's conference call to discuss Aethlon Medical's corporate developments and financial results for the second quarter fiscal 2018 ended September 30, 2017. With us today are Jim Joyce, the company's CEO; and Jim Frakes, CFO. At 4:15 p.m. Eastern time today, Aethlon Medical released financial results for the second quarter fiscal 2018 ended September 30, 2017. If you have not received Aethlon Medical's earnings release, please visit the investor's page at www.aethlonmedical.com.

During the course of this conference call, the company will be making forward-looking statements within the meaning of Section 27-A of the Securities Act of 1933 and Section 21-E of the Securities Exchange Act of 1934 that involve risks and uncertainties. The company cautions you that any statement that is not a statement of

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.